This content is machine translated German-speaking European School of Oncology in St. Gallen The pros and cons of antiangiogenic therapy in first-line treatment. At a DESO advanced training course in St. Gallen, Prof. Volker Heinemann, MD, Munich, and Prof. Werner Scheithauer, MD, Vienna, led a discussion on the use of first-line antiangiogenic therapies.…
